Nutra Pharma has completed submission of the final Nyloxin OTC and Nyloxin Rx packaging and labeling to the Food and Drug Administration (FDA). This registration is considered the final step required by the FDA to begin selling Nyloxin OTC and Nyloxin Rx in the United States for the treatment of chronic pain. (PRWeb Dec 7, 2009)
Read the full story at http://www.prweb.com/releases/NutraPharma/Nyloxin/prweb3304624.htm